Kainate-induced brain lesion: Similar local and remote histopathological and molecular changes as in ischemic brain infarct

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 7, 1996, Pages 787-794

  Liu, H Mei ^a   Lei, De Liang ^a   Yang, Dong Liang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Brain; C fos; Infarct; Ischemia; Kainic acid; Neurotoxin

Indexed keywords

EXCITOTOXIN; KAINIC ACID; PROTEIN C FOS;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GLIOSIS; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE FUNCTION; MALE; NEOCORTEX; NEOVASCULARIZATION (PATHOLOGY); NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

EID: 8944250669     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199607000-00004     Document Type: Article

References (49)

1. Brierley JB, Graham DI. Hypoxia and vascular disorders in the central nervous system. In: Adams JH, Corsallis JAN, Duchen LW, eds. Greenfield's neuropathology. London: Edward Arnold, 1984: 125-207
2. Scholz W. Topistic lesion. In: Schade JP, McMenemy WM, eds. Selective vulnerability of the brain in hypoxaemia. Oxford: Blackwell Scientific, 1984:257-67
3. Pulsinelli WA. Selective neuronal vulnerability: Morphological and molecular characteristics. Prog Brain Rev 1985;63:29-37
4. Liu HM, Chen HH. c-Fos protein expression and ischemic changes in neurons vulnerable to ischemia/hypoxia, correlated with basic fibroblast growth factor immunoreactivity. J Neuropathol Exp Neurol 1994;53:598-605
5. Meldrum B, Evans M, Griffiths T, Simon R. Ischemic brain damage: The role of excitatory activity and of calcium entry. Br J Anesth 1985;57:44-46
6. Rothman SM, Olney JW. Glutamate and pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986;19:105-11
7. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. TINS 1987;10:299-302
8. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of ischemia on the release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microanalysis. J Neurochem 1988;51:1455-64
9. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989;29:365-402
10. Siesjo BK, Bengtsson F. Calcium fluxes, calcium antagonists and calcium-related pathology in brain ischemia, hypoxia, and spreading depression: A unifying hypothesis. J Cereb Blood Flow Metab 1989;9:127-40
11. 2+ activated mechanisms in cell killing. Drug Metab 1989;20:193-201
12. Chan PH, Fishman RA, Longar S, Chen S, Yu A. Cellular and molecular effects of polyunsaturated fatty acids in brain ischemia and injury. Prog Brain Res 1985;63:227-35
13. Sheng M, Greenberg ME. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 1990;4:571-82
14. Morgan JI, Curran T. Role of ion in the control of c-fos expression. Nature 1986;322:552-55
15. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982;239:57-69
16. Olney JW, Rhee V, Ho OL. Kainic acid: A powerful neurotoxic analogue of glutamate. Brain Res 1979;77:507-12
17. Wutherthele WM, Lovel KL, Jones MZ, Moore KE. A histologic study of kainic-acid induced lesions in the rat brain. Brain Res 1978;149:487-97
18. Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW. Sensitivity of the developing rat brain to hypobaric/ischemic injury parallels sensitivity to N-methyl-D-spartate neurotoxicity. J Neurosci 1989;9:2809-18
19. Steiner HX, McBean GJ, Kohler C, Roberts PJ, Schwartz R. Ibotenate-induced neonatal degeneration in immature rat brain. Brain Res 1984;307:117-24
20. McDonald JW, Silverstein FS, Johnston MV. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 1988;459:200-3
21. Marret S, Mukendi R, Gadisseux J-F, Gressens P, Evrard P. Effect of ibotenate on brain development: An excitoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropath Exp Neurol 1995;54:358-70
22. Chen HH, Liu HM. A new fluorescent marker for ischemic neurons: EA 50: Correlated with Fos/Jun/AP1 immunoreactivity. Histochemistry 1995, in press
23. Greenberg ME, Ziff EB, Greene LA. Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science 1986;234:80-83
24. Cole AJ, Saffen DW, Baraban JM, Worley PF. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989;340:474-76
25. Uemura Y, Kowell NW, Moskowitz MA. Focal ischemia in rats causes time-dependent expression of c-fos protein immunoreactivity in widespread regions of ipsilateral cortex. Brain Res 1991;552: 99-105
26. Herdegen T, Kovary K, Leah J, Bravo R. Specific temporal and spatial distribution of JUN, FOS, and KNOX-24 proteins in spinal neurons following noxious transsynaptic stimulation. J Comp Neurol 1991;313:178-91
27. Kiessling M, Gass P. Immediate early gene expression in experimental epilepsy. Brain Pathol 1993;3:381-93
28. Bohmann D, Bos T, Admon A, Nishimura T, Vogt P, Tjian R. Human protooncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386-92
29. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P. c-jun dimerizes with itself and with c-fos, forming complexes of different binding affinities. Cell 1988;55:918-24
30. Mitchell R, Zokas L, Schreiiber RD, Verma IM. Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell 1985;40:209-13
31. Liu HM, Yang LS, Yang YJ. Schwann cell properties: 3. c-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol 1995;54:487-96
32. Sonnenberg JL, Rauscher FJ, Morgan JI, Curran T. Regulation of proenkephalin by fos and jun. Science 1989;246:1622-25
33. Naranjo JR, Mellstrom B, Achaval M. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanoncal AP-1 site in the prodynorphin gene. Neuron 1991;6:607-17
34. Zheng M, Heinrich G. Structural and functional analysis of the promotor region of the nerve growth factor gene. Mol Brain Res 1988;3:133-40
35. Hengerer B, Lindholm D, Heumann R, Ruther U, Wagner EF, Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci USA 1990;87:3899-3903
36. Liu HM, Chen HH. Correlation between basic fibroblast growth factor expression and cell proliferation in experimental brain infarct: Studied with proliferating nuclear antigen immunohistochemistry. J Neuropathol Exp Neurol 1994;53:118-26
37. Schonthal A, Herrlich P, Rahmsdorf JH, Ponta H. Requirements for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988;54:325-34
38. Smeyne RJ, Vendrell M, Hayward M, Bakers SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993;363:166-69
39. Lillie RD. In: H.J. Conn's biological stains. Baltimore: Williams and Wilkins, 1969:241
40. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991;40:599-636
41. Wessel TC, Joh TH, Volpe BT. In situ hybridization analysis of c-fos and c-jun expression in the rat brain following transient forebrain ischemia. Brain Res 1991;567:231-40
42. Morgan J, Cohen D, Hempstead J, Curran T. Mapping patterns of c-fos in the central nervous system after seizure. Science 1987;237: 192-97
43. Ben-Ari Y, Tremblay E, Ottersen OP, Meldrum BS. The role of epileptic activity in hippocampal and remote cerebral lesions induced by kainic acid. Neuroscience 1980;191:79-97
44. Freund TF, Ylinen A, Miettinen R, Pitkanen A, Lahtinen H, Baimbridge KG, Riekkinen PJ. Pattern of neuronal death in the rat hippocampus after status epilepticus, relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull 1991;28:227-38
45. Sloviter RS, Daminao BP. Sustained electrical stimulation of the perforant path duplicates kainate-induced electrophysiological effects and hippocampal damage in rats. Neurosci Lett 1981;24:279-84
46. Jones RSG. Entorhinal-hippocampal connections: Speculative view of their functions. TINS 1993;16:58-64
47. Hjorth-Simonsen A. Projection of the lateral part of the entorhinal area to the hippocampus and fascia dentate. J Comp Neurol 1972;146:219-32
48. Kohler C, Schwarcz R, Fuxe K. Perforant path transections protect hippocampal granule cells from kainate lesion. Neurosci Lett 1978;10:241-46
49. Leranth C, Ribak CE. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: A possible key to this region's resistance to epileptic damage. Exp Brain Res 1991;85:129-36